EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review

Elena Giovannini iD, Maria Paola Bonasoni iD, Michele D'Aleo, Ione Tamagnini, Matteo Tudini, Paolo Fais iD, Susi Pelotti iD

International Journal of Molecular Sciences · 30.06.2023 · 24 (13) · 10919

DOI: 10.3390/ijms241310919 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.06.2023. Verfasst von Elena Giovannini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Legal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 49, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Myocarditis, Antineoplastic Agents, Immunological, Melanoma, Myositis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health—Ricerca Corrente Annual Program 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) represent a major advance in cancer treatment. The lowered immune tolerance induced by ICIs brought to light a series of immune-related adverse events (irAEs). Pembrolizumab belongs to the ICI class and is a humanized IgG4 anti-PD-1 antibody that blocks the interaction between PD-1 and PD-L1. The ICI-related irAEs involving various organ systems and myocarditis are uncommon (incidence of 0.04% to 1.14%), but they are associated with a high reported mortality. Unlike idiopathic inflammatory myositis, ICI-related myositis has been reported to frequently co-occur with myocarditis. The triad of myasthenia, myositis, and myocarditis must not be underestimated as they can rapidly deteriorate, leading to death. Herein we report a case of a patient with metastatic melanoma who fatally developed myasthenia gravis, myocarditis, and myositis, after a single cycle of pembrolizumab. Considering evidence from the literature review, autopsy, histological, and immunohistochemical investigations on heart and skeletal muscle are presented and discussed, also from a medical–legal perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisAntineoplastic Agents, ImmunologicalMelanomaMyositisNeoplasms, Second PrimaryHumansAutopsyMuscle WeaknessAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

autopsyimmunohistochemistrymyastheniamyocarditismyositispembrolizumab

Substanzen

Antineoplastic Agents, ImmunologicalpembrolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Unit of Legal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 49, 40126 Bologna, Italy.
  • Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy.

ORCID-Profile: Elena Giovannini, Maria Paola Bonasoni, Paolo Fais, Susi Pelotti

Förderung

  • Ministero della Salute
  • Italian Ministry of Health—Ricerca Corrente Annual Program 2024

Zitieren

APA

Giovannini, E., Bonasoni, M. P., D'Aleo, M., Tamagnini, I., Tudini, M., Fais, P., & Pelotti, S. (2023). Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review. International Journal of Molecular Sciences, 24(13), 10919. https://doi.org/10.3390/ijms241310919

Vancouver

Giovannini E, Bonasoni MP, D'Aleo M, Tamagnini I, Tudini M, Fais P, et al. Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review. International Journal of Molecular Sciences. 2023;24(13):10919. doi:10.3390/ijms241310919

BibTeX
@article{Giovannini2023,
  author = {Giovannini, Elena and Bonasoni, Maria Paola and D'Aleo, Michele and Tamagnini, Ione and Tudini, Matteo and Fais, Paolo and Pelotti, Susi},
  title = {Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10919},
  doi = {10.3390/ijms241310919}
}
Kostenlos starten →